Approved Nanomedicine against Diseases

121Citations
Citations of this article
258Readers
Mendeley users who have this article in their library.

Abstract

Nanomedicine is a branch of medicine using nanotechnology to prevent and treat diseases. Nanotechnology represents one of the most effective approaches in elevating a drug‘s treatment efficacy and reducing toxicity by improving drug solubility, altering biodistribution, and controlling the release. The development of nanotechnology and materials has brought a profound revolution to medicine, significantly affecting the treatment of various major diseases such as cancer, injection, and cardiovascular diseases. Nanomedicine has experienced explosive growth in the past few years. Although the clinical transition of nanomedicine is not very satisfactory, traditional drugs still occupy a dominant position in formulation development, but increasingly active drugs have adopted nanoscale forms to limit side effects and improve efficacy. The review summarized the approved nanomedicine, its indications, and the properties of commonly used nanocarriers and nanotechnology.

Cite

CITATION STYLE

APA

Jia, Y., Jiang, Y., He, Y., Zhang, W., Zou, J., Magar, K. T., … He, W. (2023, March 1). Approved Nanomedicine against Diseases. Pharmaceutics. MDPI. https://doi.org/10.3390/pharmaceutics15030774

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free